n-methyl-3,4-methylenedioxyamphetamine has been researched along with Anochlesia in 3 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
Excerpt | Relevance | Reference |
---|
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Schmidt, WJ | 3 |
Mayerhofer, A | 2 |
Meyer, A | 1 |
Kovar, KA | 2 |
Banjaw, MY | 1 |
Lebsanft, HB | 1 |
Kohles, T | 1 |
3 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Anochlesia
Article | Year |
---|---|
Ecstasy counteracts catalepsy in rats, an anti-parkinsonian effect?
Topics: 3,4-Methylenedioxyamphetamine; Adrenergic Uptake Inhibitors; Animals; Catalepsy; Dopamine Antagonist | 2002 |
Anticataleptic activity of cathinone and MDMA (Ecstasy) upon acute and subchronic administration in rat.
Topics: Adrenergic Uptake Inhibitors; Alkaloids; Animals; Catalepsy; Central Nervous System; Central Nervous | 2003 |
3,4-Methylenedioxymethamphetamine counteracts akinesia enantioselectively in rat rotational behavior and catalepsy.
Topics: Adrenergic Uptake Inhibitors; Animals; Antiparkinson Agents; Behavior, Animal; Catalepsy; Denervatio | 2005 |